Filed: 11/13/2025ACC: 0001012975-25-000748
📋 What this filing means
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $172.98M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$172.98M
Total AUM (reported)
12.08M
Total Shares
Allocation by class
COM$129.13M74.6%
ORDINARY SHARES$40.45M23.4%
CL A$2.91M1.7%
COM NEW$503.1K0.3%
Portfolio Concentration
Top 3$129.85M75.1%
4–10$43.13M24.9%
Top 3 weight
75.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 12.08M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
12.08M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other10
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings10
Rows:
VAXCYTE INC
DFNDShares1.37M
TypeSH
Market value$49.43M
28.58%
Sole
0.00
Shared
1.37M
None
0.00
OCULIS HOLDING AG
DFNDShares2.30M
TypeSH
Market value$40.45M
23.38%
Sole
0.00
Shared
2.30M
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares2.12M
TypeSH
Market value$39.97M
23.11%
Sole
0.00
Shared
2.12M
None
0.00
ZENAS BIOPHARMA INC
DFNDShares779.04K
TypeSH
Market value$17.29M
10.00%
Sole
0.00
Shared
779.04K
None
0.00
TREVI THERAPEUTICS INC
DFNDShares1.26M
TypeSH
Market value$11.50M
6.65%
Sole
0.00
Shared
1.26M
None
0.00
IMMUNOME INC
DFNDShares502.51K
TypeSH
Market value$5.88M
3.40%
Sole
0.00
Shared
502.51K
None
0.00
BIOAGE LABS INC
DFNDShares653.37K
TypeSH
Market value$3.84M
2.22%
Sole
0.00
Shared
653.37K
None
0.00
RECURSION PHARMACEUTICALS IN
DFNDShares595.52K
TypeSH
Market value$2.91M
1.68%
Sole
0.00
Shared
595.52K
None
0.00
RALLYBIO CORP
DFNDShares2.40M
TypeSH
Market value$1.20M
0.69%
Sole
0.00
Shared
2.40M
None
0.00
BOLT BIOTHERAPEUTICS INC
DFNDShares94.57K
TypeSH
Market value$503.1K
0.29%
Sole
0.00
Shared
94.57K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VAXCYTE INCDFND | COM | 1.37M | SH | $49.43M 28.58% | 0.00 | 1.37M | 0.00 |
OCULIS HOLDING AGDFND | ORDINARY SHARES | 2.30M | SH | $40.45M 23.38% | 0.00 | 2.30M | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 2.12M | SH | $39.97M 23.11% | 0.00 | 2.12M | 0.00 |
ZENAS BIOPHARMA INCDFND | COM | 779.04K | SH | $17.29M 10.00% | 0.00 | 779.04K | 0.00 |
TREVI THERAPEUTICS INCDFND | COM | 1.26M | SH | $11.50M 6.65% | 0.00 | 1.26M | 0.00 |
IMMUNOME INCDFND | COM | 502.51K | SH | $5.88M 3.40% | 0.00 | 502.51K | 0.00 |
BIOAGE LABS INCDFND | COM | 653.37K | SH | $3.84M 2.22% | 0.00 | 653.37K | 0.00 |
RECURSION PHARMACEUTICALS INDFND | CL A | 595.52K | SH | $2.91M 1.68% | 0.00 | 595.52K | 0.00 |
RALLYBIO CORPDFND | COM | 2.40M | SH | $1.20M 0.69% | 0.00 | 2.40M | 0.00 |
BOLT BIOTHERAPEUTICS INCDFND | COM NEW | 94.57K | SH | $503.1K 0.29% | 0.00 | 94.57K | 0.00 |